REATA PHARMACEUTICALS INC Marketable Securities (Current)
REATA PHARMACEUTICALS INC had Marketable Securities (Current) of $281.37 million as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2023-08-08
- 2023-06-30: Marketable Securities, Current $281.37M.
- 2023-03-31: Marketable Securities, Current $236.02M.
- 2022-12-31: Marketable Securities, Current $345.20M.
- 2022-09-30: Marketable Securities, Current $403.96M.
| Period end | Marketable Securities, Current |
|---|---|
| 2023-06-30 | $281.37M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $236.02M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $345.20M 10-Q · filed 2023-08-08 |
| 2022-09-30 | $403.96M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $334.32M 10-Q · filed 2022-08-08 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-24 |